Custom Skincare Formulation Brief: How to Write One That Works

Direct Answer

A formulation brief is the specification that turns a brand's intent into a developable project. It needs eight sections: product category and intent; sensory and texture target; ingredient direction including required actives, concentrations, and an exclusion list; intended claims; pack format and fill; target market; cost, volume, and timeline constraints; and the documentation required on delivery. The two sections that decide whether the first sample succeeds are the sensory target and the exclusion list, because a formulator can hit a technical specification and still produce something the brand will not sell. Write the brief once, carefully, and development runs once. Write it loosely and every sample round costs a cycle.

Opening Hook

A brand sent a two-page brief describing a "light, hydrating, natural-feeling day cream for Southeast Asia" and waited. Three samples arrived over ten weeks, each technically competent and none sellable: one was too rich for a humid climate, one smelled of a raw material the brand later said it would never use, and one could not carry the whitening claim the brand had already printed on its mock-up. The formulator had not failed; the brief had no sensory target, no exclusion list, and no claim list. The brand rewrote it in eight sections, and the fourth sample was the launch product. At ubitglow, the development brief is completed with the buyer before sample work begins.

The Eight Sections of a Workable Brief

Each section answers a question the formulator would otherwise have to guess.

Data: Independent ingredient safety assessments consolidate toxicological evidence for cosmetic ingredients and give a formulator a citable basis for concentration decisions inside a development project.

Judgment: Ask the formulator which published safety references support the chosen actives at the intended use level, because a brief that fixes a concentration without a supporting reference creates a development risk that surfaces late as a reformulation.

Source: Cosmetic Ingredient Review (CIR) — CIR Ingredient Safety Assessments (2024)

Section eight is routinely omitted and routinely regretted. A formula without a transferred specification file cannot be re-sourced, re-tested, or defended.

Writing a Sensory Target a Formulator Can Reproduce

Texture is the most subjective requirement and the one most often written in adjectives that mean nothing operationally.

A formulator who receives a reproducible target can select the emulsifier system and oil phase deliberately. A formulator who receives adjectives will make a reasonable choice and be wrong half the time. The formulation stability and testing guide explains how the texture target constrains the stability programme that follows.

Data: Advertising claims must be truthful and substantiated by evidence held before publication, which places the claim list inside the development brief rather than in the marketing plan that follows it.

Judgment: Put the claim list in the brief even when the wording is undecided, because the difference between a hydrating and a clinically tested product is a study and a timeline, and a formulator can only build for a claim that has been stated.

Source: U.S. FTC — Truth in Advertising and Claim Substantiation (2024)

The Exclusion List Does More Work Than the Inclusion List

Exclusions are the cheapest risk control in formulation and the least often written down.

An exclusion list also protects the brand's claims. A product marketed as free from a substance fails on the first ingredient audit if the brief never said to exclude it.

Development Timelines and Review Points

A brief should state the review structure, not only the content, so the project has decision points.

Data: Manufacturing-practice standards for cosmetics define documentation and control expectations at the production step, which is the standard a finished specification should be written against.

Judgment: Ask for the specification file formatted to a recognised manufacturing-practice basis, because a specification the next factory cannot read is not a transferable asset even when it is technically complete.

Source: ISO — ISO 22716 Cosmetics Good Manufacturing Practices (2024)

The sample development timeline guide sets realistic expectations for these stages, and the ingredient sourcing and traceability guide covers how the exclusion list converts into a sourcing constraint.

Brief Mistakes That Cost a Development Round

Every wasted sample traces back to a missing line. Five recur in most projects.

Data: Manufacturing-practice standards for cosmetics require documented process control and records, so a specification written against a recognised basis is what makes a formula reproducible at another site.

Judgment: Ask for the documentation list in the first version of the brief rather than in a later negotiation, because a formula that transfers with its specification and test data is an asset the brand can re-source, while one that transfers alone is a dependency.

Source: ISO — ISO 22716 Cosmetics Good Manufacturing Practices (2024)

The pattern is consistent: brief defects are cheap to fix on paper and expensive to fix in a lab. Two to three pages written carefully will usually save more calendar time than any amount of pressure applied during development.

The Bottom Line

In one sentence a buyer can repeat: the brief is the product, so write eight sections and make the sensory target reproducible and the exclusion list explicit. State the claims you intend to print, name the pack, name the market, and ask for the specification file on delivery. Development cycles are wasted by missing brief sections far more often than by weak formulators.

At ubitglow, custom development starts from a completed brief covering sensory target, exclusions, claims, pack, and market, so the first sample is aimed rather than guessed.